Cancer News and Research

Latest Cancer News and Research

People infected with hepatitis D are more prone to hepatocellular carcinoma

Of all the hepatitis viruses, D is the most poorly known.This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

Climate change threatens prospects for progress in cancer prevention and control

Climate change threatens prospects for further progress in cancer prevention and control, increasing exposure to cancer risk factors and impacting access to cancer care, according to a new commentary by scientists from the American Cancer Society and Harvard T. H. Chan School of Public Health.

18 May 2020

Researchers develop potential drug compound for treating cancer

Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells.

18 May 2020

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space - an emerging area in cancer immunology.

From Boehringer Ingelheim International GmbH 18 May 2020

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.

18 May 2020

Tobacco companies exploit UK’s menthol cigarette ban

Menthol cigarettes will be removed from shelves in the UK this Wednesday (20 May 2020), yet new research has found that tobacco companies failed to use the four-year phasing-in period (from 2016) to prepare for this week's ban.

18 May 2020

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Researchers in Frankfurt, Germany, have described cell signaling events that occur when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells and have identified pathways that are essential for the virus to replicate.

17 May 2020

Experts publish a review of lung cancer treatments for patients with COVID-19

Lung cancer patients are at heightened risk for COVID-19 and the reported high mortality rate among lung cancer patients with COVID-19 has given pause to oncologists who are faced with patients with not one, but two severe, life-threatening diseases.

15 May 2020

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

The Networks of Centres of Excellence recently announced its continued support in Canadian glycomics research with a three-year investment of $16.3 million through the Canadian Glycomics Network (GlycoNet).

15 May 2020

Antiviral drug can help accelerate recovery of COVID-19 patients, study shows

An international team of researchers led by Dr. Eleanor Fish, emerita scientist at the Toronto General Hospital Research Institute, University Health Network, and professor in the University of Toronto's Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.

15 May 2020

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) -- the most common and the most aggressive brain cancer -- has simply been age at diagnosis.

15 May 2020

Interdisciplinary team to develop a new physics-based technology for COVID-19 detection

One of the most challenging aspects of the COVID-19 pandemic has been the lack of testing needed to detect and trace infections--and without adequate testing, government officials do not have the data they need to make the best possible decisions in the interest of public health.

15 May 2020

New book demystifies the molecular biology of breast cancer

Breast cancer is known as one of the most deadly diseases among women. However, recent advancements in the imaging tools and diagnostic methods for breast cancer has improved the screening in the past few years.

15 May 2020

Study finds high variability in access to, and quality of, bone density scanning facilities worldwide

There is high variability in access to, and quality of, bone density scanning facilities worldwide, according to a landmark global study carried out at the Medical Research Council Lifecourse Epidemiology Unit in collaboration with the International Osteoporosis Foundation and the International Society for Clinical Densitometry.

15 May 2020

UCLA-led clinical trial to assess if hormone suppresser will reduce COVID-19 severity in men

UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19.

15 May 2020

Study: Most uncommon infections and major vascular events are likely to be misdiagnosed

New research provides estimates of diagnostic error and serious misdiagnosis-related harm rates for each of the five most frequently misdiagnosed major vascular events, infections, and cancers in the U.S.

15 May 2020

University of Greenwich develops compounds that can fight COVID-19 killer

Covid-19 treatment that could potentially also help protect cancer and organ transplant patients is being developed at the University of Greenwich.

15 May 2020

Developing a COVID-19 antigen test

News-Medical speaks to Alastair Smith, the CEO of Avacta, about the process behind their newly developed antigen test for COVID-19.

From Avacta Life Sciences Ltd. 15 May 2020

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.

15 May 2020

Study shows the combined effect of inherited and acquired mutations on cancer development

The common belief that tumors arise via activation of a few genes that "drive" cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.

15 May 2020

Cancer News and Research

Latest Cancer News and Research

People infected with hepatitis D are more prone to hepatocellular carcinoma

Climate change threatens prospects for progress in cancer prevention and control

Researchers develop potential drug compound for treating cancer

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Tobacco companies exploit UK’s menthol cigarette ban

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Experts publish a review of lung cancer treatments for patients with COVID-19

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

Antiviral drug can help accelerate recovery of COVID-19 patients, study shows

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

Interdisciplinary team to develop a new physics-based technology for COVID-19 detection

New book demystifies the molecular biology of breast cancer

Study finds high variability in access to, and quality of, bone density scanning facilities worldwide

UCLA-led clinical trial to assess if hormone suppresser will reduce COVID-19 severity in men

Study: Most uncommon infections and major vascular events are likely to be misdiagnosed

University of Greenwich develops compounds that can fight COVID-19 killer

Developing a COVID-19 antigen test

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Study shows the combined effect of inherited and acquired mutations on cancer development

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in